- Home
- Publications
- Publication Search
- Publication Details
Title
Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 4, Pages 538
Publisher
MDPI AG
Online
2019-04-15
DOI
10.3390/cancers11040538
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glasdegib: First Global Approval
- (2019) Sheridan M. Hoy DRUGS
- Increased Programmed Death-Ligand 1 is an Early Epithelial Cell Response to Helicobacter pylori Infection
- (2019) Loryn Holokai et al. PLoS Pathogens
- Loss of primary cilia drives switching from Hedgehog to Ras/MAPK pathway in resistant basal cell carcinoma
- (2019) François Kuonen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Effective anti-programmed death-1 therapy in a SUFU -mutated patient with Gorlin-Goltz syndrome
- (2018) A. Moreira et al. BRITISH JOURNAL OF DERMATOLOGY
- Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma
- (2018) Markus Eberl et al. CANCER CELL
- Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer
- (2018) Jordi Rodon et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma
- (2018) Johanna Bendell et al. CLINICAL CANCER RESEARCH
- Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS
- (2018) Michael R. Savona et al. CLINICAL CANCER RESEARCH
- Synergistic Cross-Talk of Hedgehog and Interleukin-6 Signaling Drives Growth of Basal Cell Carcinoma
- (2018) Christina Sternberg et al. INTERNATIONAL JOURNAL OF CANCER
- Noncanonical hedgehog pathway activation through SRF–MKL1 promotes drug resistance in basal cell carcinomas
- (2018) Ramon J Whitson et al. NATURE MEDICINE
- Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy
- (2018) Nagendra K. Chaturvedi et al. Oncotarget
- Anti-PD-1 Therapy Leads to Near-Complete Remission in a Patient with Metastatic Basal Cell Carcinoma
- (2018) Stefanie Fischer et al. Oncology Research and Treatment
- Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity
- (2018) Bonnie W. Lau et al. ONCOGENE
- Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma
- (2018) Teresa Purzner et al. Science Signaling
- Structural Basis for Cholesterol Transport-like Activity of the Hedgehog Receptor Patched
- (2018) Yunxiao Zhang et al. CELL
- Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies
- (2018) Bastian von Tresckow et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
- (2018) Jorge E. Cortes et al. LEUKEMIA
- Cilia-Associated Oxysterols Activate Smoothened
- (2018) David R. Raleigh et al. MOLECULAR CELL
- A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition
- (2018) Brian Biehs et al. NATURE
- A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy
- (2018) Adriana Sánchez-Danés et al. NATURE
- Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer
- (2018) Jayati Chakrabarti et al. Oncotarget
- Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance
- (2017) Wolfgang Gruber et al. INTERNATIONAL JOURNAL OF CANCER
- The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer
- (2017) A Szczepny et al. ONCOGENE
- Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma
- (2017) A Po et al. ONCOGENE
- Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma
- (2017) Sonia Coni et al. Scientific Reports
- Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
- (2017) Evan J. Lipson et al. Journal for ImmunoTherapy of Cancer
- Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Jean Y Tang et al. LANCET ONCOLOGY
- Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment
- (2016) Ann Hanna et al. Molecular Cancer
- Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma
- (2016) B. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
- (2016) Ximena Bonilla et al. NATURE GENETICS
- Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
- (2016) Andrew P. Feinberg et al. NATURE REVIEWS GENETICS
- Primary Cilia and Mammalian Hedgehog Signaling
- (2016) Fiona Bangs et al. Cold Spring Harbor Perspectives in Biology
- DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance
- (2016) Wolfgang Gruber et al. Oncotarget
- Invasive mouse gastric adenocarcinomas arising from Lgr5+ stem cells are dependent on crosstalk between the Hedgehog/GLI2 and mTOR pathways
- (2016) Li-Jyun Syu et al. Oncotarget
- Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy
- (2015) Laura Di Magno et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
- (2015) Scott X. Atwood et al. CANCER CELL
- Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
- (2015) Hayley J. Sharpe et al. CANCER CELL
- RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors
- (2015) X. Zhao et al. CANCER RESEARCH
- Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia
- (2015) D Kern et al. ONCOGENE
- Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia
- (2015) Yiting Lim et al. Science Translational Medicine
- Targeting GLI factors to inhibit the Hedgehog pathway
- (2015) Paola Infante et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- SnapShot: Medulloblastoma
- (2014) Jessica M. Rusert et al. CANCER CELL
- Pyrvinium Attenuates Hedgehog Signaling Downstream of Smoothened
- (2014) Bin Li et al. CANCER RESEARCH
- Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors
- (2014) P. Infante et al. EMBO JOURNAL
- The BET Bromodomain Inhibitor I-BET151 Acts Downstream of Smoothened Protein to Abrogate the Growth of Hedgehog Protein-driven Cancers
- (2014) Jun Long et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
- (2014) Yujie Tang et al. NATURE MEDICINE
- G-protein-coupled receptors, Hedgehog signaling and primary cilia
- (2014) Saikat Mukhopadhyay et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Canonical and non-canonical Hedgehog signalling and the control of metabolism
- (2014) Raffaele Teperino et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Context-dependent signal integration by the GLI code: The oncogenic load, pathways, modifiers and implications for cancer therapy
- (2014) Fritz Aberger et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Gli Protein Activity Is Controlled by Multisite Phosphorylation in Vertebrate Hedgehog Signaling
- (2014) Pawel Niewiadomski et al. Cell Reports
- Advanced Treatment for Basal Cell Carcinomas
- (2014) S. X. Atwood et al. Cold Spring Harbor Perspectives in Medicine
- Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists
- (2013) James Kim et al. CANCER CELL
- Inhibition of Hedgehog signaling in the gastrointestinal tract: Targeting the cancer microenvironment
- (2013) Juanita L. Merchant et al. CANCER TREATMENT REVIEWS
- Discovery of NVP-LEQ506, a Second-Generation Inhibitor of Smoothened
- (2013) Stefan Peukert et al. ChemMedChem
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- (2013) A. Jimeno et al. CLINICAL CANCER RESEARCH
- Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant
- (2013) Tsuyoshi Ishii et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling
- (2013) Naokazu Ibuki et al. INTERNATIONAL JOURNAL OF CANCER
- GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas
- (2013) Scott X. Atwood et al. NATURE
- Structure of the human smoothened receptor bound to an antitumour agent
- (2013) Chong Wang et al. NATURE
- The mechanisms of Hedgehog signalling and its roles in development and disease
- (2013) James Briscoe et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Gli2 Acetylation at Lysine 757 Regulates Hedgehog-Dependent Transcriptional Output by Preventing Its Promoter Occupancy
- (2013) Sonia Coni et al. PLoS One
- Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: Modification of the core skeleton for improved solubility
- (2012) Tomohiro Ohashi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
- (2012) Yan Wang et al. CANCER CELL
- Hedgehog Partial Agonism Drives Warburg-like Metabolism in Muscle and Brown Fat
- (2012) Raffaele Teperino et al. CELL
- Hedgehog Signaling in Hematopoiesis
- (2012) Yiting Lim et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells
- (2012) Markus Eberl et al. EMBO Molecular Medicine
- Basal cell carcinoma — molecular biology and potential new therapies
- (2012) Maria Kasper et al. JOURNAL OF CLINICAL INVESTIGATION
- Defining the mode of tumour growth by clonal analysis
- (2012) Gregory Driessens et al. NATURE
- Vismodegib
- (2012) Andrzej Dlugosz et al. NATURE REVIEWS DRUG DISCOVERY
- Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome
- (2012) Jean Y. Tang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model
- (2012) M. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HEDGEHOG-GLI Signaling Drives Self-Renewal and Tumorigenicity of Human Melanoma-Initiating Cells
- (2012) Roberta Santini et al. STEM CELLS
- Gli Proteins in Development and Disease
- (2011) Chi-chung Hui et al. Annual Review of Cell and Developmental Biology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Small Molecule Antagonists in Distinct Binding Modes Inhibit Drug-Resistant Mutant of Smoothened
- (2011) Haiyan Tao et al. CHEMISTRY & BIOLOGY
- Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- A Polymeric Nanoparticle Encapsulated Small-Molecule Inhibitor of Hedgehog Signaling (NanoHHI) Bypasses Secondary Mutational Resistance to Smoothened Antagonists
- (2011) V. Chenna et al. MOLECULAR CANCER THERAPEUTICS
- A crucial requirement for Hedgehog signaling in small cell lung cancer
- (2011) Kwon-Sik Park et al. NATURE MEDICINE
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Sonic Hedgehog Dependent Phosphorylation by CK1α and GRK2 Is Required for Ciliary Accumulation and Activation of Smoothened
- (2011) Yongbin Chen et al. PLOS BIOLOGY
- Hedgehog beyond medulloblastoma and basal cell carcinoma
- (2010) Stephan Teglund et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
- (2010) James Kim et al. CANCER CELL
- Targeting Hedgehog -- a Cancer Stem Cell Pathway
- (2010) A. A. Merchant et al. CLINICAL CANCER RESEARCH
- Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
- (2010) Elspeth M. Beauchamp et al. JOURNAL OF CLINICAL INVESTIGATION
- Histone deacetylase and Cullin3–RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation
- (2010) Gianluca Canettieri et al. NATURE CELL BIOLOGY
- The primary cilium: a signalling centre during vertebrate development
- (2010) Sarah C. Goetz et al. NATURE REVIEWS GENETICS
- DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS
- (2010) Matthias Lauth et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
- (2010) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma
- (2010) S. Buonamici et al. Science Translational Medicine
- Context-dependent Regulation of the GLI Code in Cancer by HEDGEHOG and Non-HEDGEHOG Signals
- (2010) B. Stecca et al. Journal of Molecular Cell Biology
- Computational Prediction and Experimental Verification of New MAP Kinase Docking Sites and Substrates Including Gli Transcription Factors
- (2010) Thomas C. Whisenant et al. PLoS Computational Biology
- Epidermal Growth Factor Receptor Signaling Synergizes with Hedgehog/GLI in Oncogenic Transformation via Activation of the MEK/ERK/JUN Pathway
- (2009) Harald Schnidar et al. CANCER RESEARCH
- Hedgehog signalling in breast cancer
- (2009) M. Kasper et al. CARCINOGENESIS
- Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion
- (2009) Frédéric Varnat et al. EMBO Molecular Medicine
- Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer
- (2009) Maria–Theresa Mueller et al. GASTROENTEROLOGY
- GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation
- (2009) O. Nolan-Stevaux et al. GENES & DEVELOPMENT
- GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein
- (2009) Elspeth Beauchamp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)
- (2009) Martin R. Tremblay et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
- (2009) Chen Zhao et al. NATURE
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
- (2009) Charles M. Rudin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
- (2009) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
- (2009) L Yang et al. ONCOGENE
- GLI1 Is a Central Mediator of EWS/FLI1 Signaling in Ewing Tumors
- (2009) Jay Joo et al. PLoS One
- Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade
- (2009) J. M. Hyman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hedgehog signal transduction by Smoothened: Pharmacologic evidence for a 2-step activation process
- (2009) R. Rohatgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
- (2009) R. L. Yauch et al. SCIENCE
- Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation
- (2008) Christine Dierks et al. CANCER CELL
- Application of Active and Kinase-Deficient Kinome Collection for Identification of Kinases Regulating Hedgehog Signaling
- (2008) Markku Varjosalo et al. CELL
- The role of kinases in the Hedgehog signalling pathway
- (2008) Reid A Aikin et al. EMBO REPORTS
- Hedgehog: functions and mechanisms
- (2008) M. Varjosalo et al. GENES & DEVELOPMENT
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- Crypt stem cells as the cells-of-origin of intestinal cancer
- (2008) Nick Barker et al. NATURE
- Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/β-catenin signaling
- (2008) Steven Hoseong Yang et al. NATURE GENETICS
- -Arrestin-Mediated Localization of Smoothened to the Primary Cilium
- (2008) J. J. Kovacs et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started